Background: Various types of gastro-intestinal complications have already been reported after atrial fibrillation (AF) radiofrequency ablation. The objective of this prospective study was to assess the incidence of esogastric injuries after pulmonary vein isolation (PVI) with the cryoballoon catheter (Arctic Front, Cryocath, Quebec, Canada).
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Methods: All patients undergoing VT ablation in 3 tertiary care centers between 2001 and 2007 were included in this study. Of 913 VT ablations, 156 procedures (17%) involved epicardial mapping and/or ablation. These were performed in 134 patients (109 male, 56 ±15yo), after a previous VT ablation in 119 (76%). The underlying substrate was ischemic cardiomyopathy (CMP) in 51, non ischemic CMP in 39, Arrhythmogenic Right Ventricular Cardiomyopathy in 13, and others types of CMPs in 31.
Results:
Epicardial access was obtained via percutaneous subxyphoid puncture in 136 procedures, by a surgical subxyphoid approach in 14 and during open heart surgery in 6. Epicardial ablation (13±12min; median: 10min) was performed in 121/156 procedures (78%). Nineteen patients subsequently required repeat procedure(s) and the epicardium could be re-accessed in all but one patient.
A total of 8/156 (5 %) major complications related to pericardial access were observed acutely: 7 epicardial bleeding (>100cc) [all bleeding stopped spontaneously] and 1 coronary stenosis.
After a mean follow-up of 23±21months, 3 delayed complications related to pericardial access, were noted (1 major pericardial inflammatory reaction, 1 delayed tamponade and 1 coronary occlusion 2 weeks after the procedure).
Conclusion:
VT ablation requires epicardial mapping and ablation in 121/ 913 (13%) procedures with a risk of 5% and 2% of acute and delayed major complications related to epicardial access.
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Methods and results:
We prospectively enrolled 24 patients under 75 years: 15 men and 9 women of mean age 48.8± 13.6 years who experienced cryptogenic IS presumed of cardioembolic mechanism within the last 4 months. Any cause of IS was excluded by normal 12-lead ECG, 24hour Holter monitoring, echocardiography, cervical Doppler, haematological and inflammatory tests. All patients underwent electrophysiological study. 7 patients (29.2%) had inducible arrhythmia during programmed atrial stimulation and 9 (37.5%) had a latent vulnerability index (LVI) <2.5. Patients were secondarily implanted with an implantable loop recorder (ILR) (Medtronic TM Reveal Plus 9526) to look for spontaneous AF over a mean follow-up interval of 14.5 months. No sustained arrhythmia was found. Only one patient had non significant AF access (<30 s). In this patient, it was not triggered sustained arrhythmia but the LVI was low.
Conclusion:
This study shows that contrary to what was expected, AF does not appear to be a common pathology in patients under 75 years with unexplained IS. The use of ILR should not be generalized in the systematic assessment of these patients because of its unprofitability. Finally this study attests the poor value of atrial vulnerability study for predicting spontaneous AF in such patients.
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